VISE Spring Seminar – Cathy Eng, MD
VISE Spring Seminar
to be lead by
Cathy Eng,MD, FACP, FASCO,
David H. Johnson Chair in Surgical and Medical Oncology, Co-Leader,
Gastrointestinal Cancer Research Program,
Professor of Medicine (Hematology and Oncology), VUMC
Date: Thursday, January 30, 2020
Location: Stevenson Center 5326
Time: 12:15 p.m. lunch, with a 12:25 p.m. start
Neoadjuvant Strategies: Locally Advanced Rectal Cancer
Abstract: Colorectal cancer is one of the major leading causes of death in both men and women. The successful management of colon or rectal cancer demands a multidisciplinary approach. In the last few years, significant improvement has been noticed in the management of localized rectal cancer to reduce local recurrence and obtain complete pathological response following appropriate surgical steps, if necessary. Implementation of neoadjuvant therapy not only enhances disease control, it may also ensure sphincter preserving procedures or organ-preserving options. This article principally concentrates on the current neoadjuvant treatment for locally advanced rectal cancer and the prognostic outcomes of such therapy, including a discussion on the historical perspective.
Short Bio: Cathy Eng, MD, FACP, FASCO, Professor of Medicine, Hematology and Oncology, and is the Co-Director of GI Oncology and Co-Leader of the Gastrointestinal Cancer Research Program. She joined the faculty at Vanderbilt-Ingram Cancer Center in July 2019. Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal, and appendiceal cancers. She has a specific interest in young colorectal cancer patients as well as the role of immunotherapy in HPV-associated cancers. She has published multiple publications in these GI malignancies. Nationally, Dr. Eng has served in multiple leadership roles for ASCO, ASCO GI, ECOG, and the NCI Rectal/Anal Task Force. She has most recently been chosen to serve as the Vice-Chair for the SWOG GI Committee and the NCI GI Steering Committee.